Investor Presentaiton
Novo Nordisk Annual Report 2023
Financial statements of the parent company
Financial statements of the parent company 2023
The following pages comprise the financial statements of the parent company, the legal entity Novo Nordisk A/S. Apart from ownership of the subsidiaries in the
Novo Nordisk Group, activity within the parent company mainly comprises sales, research and development, production, corporate activities and support functions.
Income statement
For the year ended 31 December
Balance sheet
At 31 December
DKK million
Net sales
Note
2023
2022
DKK million
Note
2023
2022
DKK million
Note
2023
2022
2
198,078
142,656
Assets
Equity and liabilities
Cost of goods sold
3
(38,433)
(31,060)
Intangible assets
6
28,755
19,449
Share capital
10
10
451
456
Gross profit
159,645
111,596
Property, plant and equipment
7
53,822
34,547
Net revaluation reserve
24,696
17,785
Sales and distribution costs
3
(42,291)
(37,476)
Financial assets
8
87,543
78,306
Development costs reserve
1,756
1,524
Research and development costs
3
(28,731)
(19,209)
Other receivables and prepayments
9
1,238
Reserve for cash flow hedges and exchange
rate adjustments
1,594
1,045
Administrative costs
3
(2,002)
(2,135)
Total non-current assets
171,358
132,302
Retained earnings
77,185
62,091
Other operating income and expenses
1,315
1,012
Raw materials
8,415
5,659
Total equity
105,682
82,901
Operating profit
87,936
53,788
Work in progress
16,211
13,657
Borrowings
12
16,855
21,199
Profit in subsidiaries, net of tax
8
15,973
19,238
Finished goods
4,311
2,975
Deferred income tax liabilities
5
6,282
2,967
Financial income
4
3,636
567
Inventories
28,937
22,291
Other provisions
13
1,280
1,303
Financial expenses
4
(4,581)
(6,280)
Trade receivables
2,348
1,877
Total non-current liabilities
24,417
25,469
Profit before income taxes
102,964
67,313
Amounts owed by affiliated companies
30,398
18,192
Borrowings
12
5,072
169
Income taxes
Net profit
(19,557)
83,407
(11,975)
Tax receivables
8
7
Derivative financial instruments
11
1,272
2,903
55,338
Other receivables and prepayments
9
5,494
3,185
Trade payables
6,778
4,782
Receivables
38,248
23,261
Amounts owed to affiliated companies
108,865
74,059
Marketable securities
15,838
10,921
Tax payables
3,046
3,115
Derivative financial instruments
11
2,344
2,727
Other liabilities
12,216
7,899
Cash at bank
10,623
9,795
Total current liabilities
137,249
92,927
Total current assets
95,990
68,995
Total liabilities
161,666
118,396
Total assets
267,348
201,297
Total equity and liabilities
267,348
201,297
105View entire presentation